TY  - JOUR
A1  - Waider, J
A1  - Popp, S
A1  - Lange, MD
A1  - Kern, R
A1  - Kolter, JF
A1  - Kobler, J
A1  - Donner, NC
A1  - Lowe, KR
A1  - Malzbender, JH
A1  - Brazell, CJ
A1  - Arnold, MR
A1  - Aboagye, B
A1  - Schmitt-Böhrer, A
A1  - Lowry, CA
A1  - Pape, HC
A1  - Lesch, KP
T1  - Genetically driven brain serotonin deficiency facilitates panic-like escape behavior in mice
JF  - Translational Psychiatry
N2  - Multiple lines of evidence implicate brain serotonin (5-hydroxytryptamine; 5-HT) system dysfunction in the pathophysiology of stressor-related and anxiety disorders. Here we investigate the influence of constitutively deficient 5-HT synthesis on stressor-related anxiety-like behaviors using Tryptophan hydroxylase 2 (Tph2) mutant mice. Functional assessment of c-Fos after associated foot shock, electrophysiological recordings of GABAergic synaptic transmission, differential expression of the Slc6a4 gene in serotonergic neurons were combined with locomotor and anxiety-like measurements in different contextual settings. Our findings indicate that constitutive Tph2 inactivation and consequential lack of 5-HT synthesis in Tph2 null mutant mice (Tph2\(^{-/-}\)) results in increased freezing to associated foot shock and a differential c-Fos activity pattern in the basolateral complex of the amygdala. This is accompanied by altered GABAergic transmission as observed by recordings of inhibitory postsynaptic currents on principal neurons in the basolateral nucleus, which may explain increased fear associated with hyperlocomotion and escape-like responses in aversive inescapable contexts. In contrast, lifelong 5-HT deficiency as observed in Tph2 heterozygous mice (Tph\(^{+/-}\)) is able to be compensated through reduced GABAergic transmission in the basolateral nucleus of the amygdala based on Slc6a4 mRNA upregulation in subdivisions of dorsal raphe neurons. This results in increased activity of the basolateral nucleus of the amygdala due to associated foot shock. In conclusion, our results reflect characteristic syndromal dimensions of panic disorder and agoraphobia. Thus, constitutive lack of 5-HT synthesis influence the risk for anxiety- and stressor-related disorders including panic disorder and comorbid agoraphobia through the absence of GABAergic-dependent compensatory mechanisms in the basolateral nucleus of the amygdala.
KW  - anxiety
KW  - stress
KW  - serotonin
KW  - genetics
KW  - mice
Y1  - 2017
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-170239
VL  - 7
IS  - e1246
ER  - 
TY  - JOUR
A1  - Leibold, NK
A1  - van den Hove, DLA
A1  - Viechtbauer, W
A1  - Buchanan, GF
A1  - Goossens, L
A1  - Lange, I
A1  - Knuts, I
A1  - Lesch, KP
A1  - Steinbusch, HWM
A1  - Schruers, KRJ
T1  - CO\(_{2}\) exposure as translational cross-species experimental model for panic
JF  - Translational Psychiatry
N2  - The current diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders are being challenged by the heterogeneity and the symptom overlap of psychiatric disorders. Therefore, a framework toward a more etiology-based classification has been initiated by the US National Institute of Mental Health, the research domain criteria project. The basic neurobiology of human psychiatric disorders is often studied in rodent models. However, the differences in outcome measurements hamper the translation of knowledge. Here, we aimed to present a translational panic model by using the same stimulus and by quantitatively comparing the same outcome measurements in rodents, healthy human subjects and panic disorder patients within one large project. We measured the behavioral–emotional and bodily response to CO\(_{2}\) exposure in all three samples, allowing for a reliable cross-species comparison. We show that CO\(_{2}\) exposure causes a robust fear response in terms of behavior in mice and panic symptom ratings in healthy volunteers and panic disorder patients. To improve comparability, we next assessed the respiratory and cardiovascular response to CO\(_{2}\), demonstrating corresponding respiratory and cardiovascular effects across both species. This project bridges the gap between basic and human research to improve the translation of knowledge between these disciplines. This will allow significant progress in unraveling the etiological basis of panic disorder and will be highly beneficial for refining the diagnostic categories as well as treatment strategies.
KW  - translational panic model
KW  - CO\(_{2}\) exposure
KW  - humans
KW  - mice
KW  - panic disorder
KW  - cross-species comparison
KW  - fear response
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-168308
VL  - 6
IS  - e885
ER  - 
TY  - JOUR
A1  - Zayats, T
A1  - Jacobsen, KK
A1  - Kleppe, R
A1  - Jacob, CP
A1  - Kittel-Schneider, S
A1  - Ribasés, M
A1  - Ramos-Quiroga, JA
A1  - Richarte, V
A1  - Casas, M
A1  - Mota, NR
A1  - Grevet, EH
A1  - Klein, M
A1  - Corominas, J
A1  - Bralten, J
A1  - Galesloot, T
A1  - Vasquez, AA
A1  - Herms, S
A1  - Forstner, AJ
A1  - Larsson, H
A1  - Breen, G
A1  - Asherson, P
A1  - Gross-Lesch, S
A1  - Lesch, KP
A1  - Cichon, S
A1  - Gabrielsen, MB
A1  - Holmen, OL
A1  - Bau, CHD
A1  - Buitelaar, J
A1  - Kiemeney, L
A1  - Faraone, SV
A1  - Cormand, B
A1  - Franke, B
A1  - Reif, A
A1  - Haavik, J
A1  - Johansson, S
T1  - Exome chip analyses in adult attention deficit hyperactivity disorder
JF  - Translational Psychiatry
N2  - Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable childhood-onset neuropsychiatric condition, often persisting into adulthood. The genetic architecture of ADHD, particularly in adults, is largely unknown. We performed an exome-wide scan of adult ADHD using the Illumina Human Exome Bead Chip, which interrogates over 250 000 common and rare variants. Participants were recruited by the International Multicenter persistent ADHD CollaboraTion (IMpACT). Statistical analyses were divided into 3 steps: (1) gene-level analysis of rare variants (minor allele frequency (MAF)<1%); (2) single marker association tests of common variants (MAF⩾1%), with replication of the top signals; and (3) pathway analyses. In total, 9365 individuals (1846 cases and 7519 controls) were examined. Replication of the most associated common variants was attempted in 9847 individuals (2077 cases and 7770 controls) using fixed-effects inverse variance meta-analysis. With a Bonferroni-corrected significance level of 1.82E−06, our analyses of rare coding variants revealed four study-wide significant loci: 6q22.1 locus (P=4.46E−08), where NT5DC1 and COL10A1 reside; the SEC23IP locus (P=6.47E−07); the PSD locus (P=7.58E−08) and ZCCHC4 locus (P=1.79E−06). No genome-wide significant association was observed among the common variants. The strongest signal was noted at rs9325032 in PPP2R2B (odds ratio=0.81, P=1.61E−05). Taken together, our data add to the growing evidence of general signal transduction molecules (NT5DC1, PSD, SEC23IP and ZCCHC4) having an important role in the etiology of ADHD. Although the biological implications of these findings need to be further explored, they highlight the possible role of cellular communication as a potential core component in the development of both adult and childhood forms of ADHD.
KW  - chip analyses
KW  - ADHD
KW  - adulthood
KW  - Illumina Human Exome Bead Chip
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-168297
VL  - 6
IS  - e923
ER  - 
TY  - JOUR
A1  - Rivero, O
A1  - Selten, MM
A1  - Sich, S
A1  - Popp, S
A1  - Bacmeister, L
A1  - Amendola, E
A1  - Negwer, M
A1  - Schubert, D
A1  - Proft, F
A1  - Kiser, D
A1  - Schmitt, AG
A1  - Gross, C
A1  - Kolk, SM
A1  - Strekalova, T
A1  - van den Hove, D
A1  - Resink, TJ
A1  - Kasir, N Nadif
A1  - Lesch, KP
T1  - Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition
JF  - Translational Psychiatry
N2  - Cadherin-13 (CDH13), a unique glycosylphosphatidylinositol-anchored member of the cadherin family of cell adhesion molecules, has been identified as a risk gene for attention-deficit/hyperactivity disorder (ADHD) and various comorbid neurodevelopmental and psychiatric conditions, including depression, substance abuse, autism spectrum disorder and violent behavior, while the mechanism whereby CDH13 dysfunction influences pathogenesis of neuropsychiatric disorders remains elusive. Here we explored the potential role of CDH13 in the inhibitory modulation of brain activity by investigating synaptic function of GABAergic interneurons. Cellular and subcellular distribution of CDH13 was analyzed in the murine hippocampus and a mouse model with a targeted inactivation of Cdh13 was generated to evaluate how CDH13 modulates synaptic activity of hippocampal interneurons and behavioral domains related to psychopathologic (endo) phenotypes. We show that CDH13 expression in the cornu ammonis (CA) region of the hippocampus is confined to distinct classes of interneurons. Specifically, CDH13 is expressed by numerous parvalbumin and somatostatin-expressing interneurons located in the stratum oriens, where it localizes to both the soma and the presynaptic compartment. Cdh13\(^{-/-}\) mice show an increase in basal inhibitory, but not excitatory, synaptic transmission in CA1 pyramidal neurons. Associated with these alterations in hippocampal function, Cdh13\(^{-/-}\) mice display deficits in learning and memory. Taken together, our results indicate that CDH13 is a negative regulator of inhibitory synapses in the hippocampus, and provide insights into how CDH13 dysfunction may contribute to the excitatory/inhibitory imbalance observed in neurodevelopmental disorders, such as ADHD and autism.
KW  - genome-wide association
KW  - deficit hyperactivity disorder
KW  - psychiatric disorders
KW  - neurodevelopmental disorders
KW  - synaptic plasticity
KW  - response inhibition
KW  - positive interneurons
KW  - T-cadherin
KW  - long-term potentiation
KW  - attention deficit/hyperactivity disorder
Y1  - 2015
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-145218
VL  - 5
IS  - e655
ER  -